Integrated mechanistic modeling approaches in oncology drug development Webinar Integrated mechanistic modeling approaches in oncology drug development CertaraJuly 8, 2026
PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05% Poster PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05% Learn how Simcyp PBPK modeling established bioequivalence and supported FDA approval of a generic productCertaraJuly 1, 2026
The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors On-Demand Webinar The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…CertaraJuly 1, 2026
Mechanistic Surface pH Modelling Improves PBPK Prediction of a Weakly Acidic Drug: Case Study of Bempedoic Acid Poster Mechanistic Surface pH Modelling Improves PBPK Prediction of a Weakly Acidic Drug: Case Study of Bempedoic Acid Explore how mechanistic surface pH modeling in Simcyp improves PBPK prediction of dissolution-controlled absorption for…CertaraJune 26, 2026
Dermal PBPK Modelling of Propylparaben with a Novel Skin Metabolism Framework Poster Dermal PBPK Modelling of Propylparaben with a Novel Skin Metabolism Framework Explore how a mechanistic dermal PBPK model with experimentally scaled, layer-specific skin metabolism predicts propylparaben…CertaraJune 26, 2026
Application of PBPK Modelling to Explore Complex Food Effects on Trospium Chloride Pharmacokinetics Poster Application of PBPK Modelling to Explore Complex Food Effects on Trospium Chloride Pharmacokinetics Discover how PBPK modeling with Simcyp mechanistically explains the formulation-dependent negative food effect of trospium…CertaraJune 26, 2026
Cross-Version Simcyp Simulator Performance Assessment Using a Bioequivalence Framework for EMA Qualification Poster Cross-Version Simcyp Simulator Performance Assessment Using a Bioequivalence Framework for EMA Qualification Learn how Certara used a bioequivalence-based TOST framework to demonstrate that Simcyp Simulator versions V20–V24…CertaraJune 26, 2026
PBPK Modelling of Bispecific Monoclonal Antibody Tumour Targeting Specificity Poster PBPK Modelling of Bispecific Monoclonal Antibody Tumour Targeting Specificity Explore how PBPK modelling evaluates the in vivo tumour-targeting specificity of bispecific monoclonal antibodies (bsmAbs),…CertaraJune 25, 2026
Sex-Specific Bioequivalence Outcomes: PBPK Insights into Gastric Emptying Variability Poster Sex-Specific Bioequivalence Outcomes: PBPK Insights into Gastric Emptying Variability Discover how sex-dependent within-subject variability in gastric emptying time influences supersaturation, precipitation, and Cmax in…CertaraJune 25, 2026
PBPK Modelling of Formulation-Dependent Food Effects for Itraconazole Oral Solution Poster PBPK Modelling of Formulation-Dependent Food Effects for Itraconazole Oral Solution Explore mechanistic PBPK modelling of itraconazole oral solution, revealing how bile salt–cyclodextrin interactions drive a…CertaraJune 25, 2026